cnbc.comThese stocks are overbought with S&P 500 near record highs and are vulnerable to pullback5 days ago
benzinga.comIncyte Surges Past Expectations With Strong Q2, Boosts Guidance On Jakafi Demand23 days ago
benzinga.comNotable Insider Move: William Meury Takes Part In Options Exercise At Incyte, Resulting In $0about 2 months ago
benzinga.comIncyte's Experimental Therapy Shows Platelet Normalization And Safety In Rare Blood Cancer Trials Across Doses2 months ago
prnewswire.comSpecialised Therapeutics Expands Partnership with Incyte to Include Two Additional Therapies for Hard-to-Treat Conditions2 months ago
CashuIncyte Stock Surges Amid Positive Myelofibrosis Therapy Outlook and Wells Fargo Upgrade3 days ago
CashuIncyte Corporation: Navigating Mixed Analyst Views in Biopharmaceutical Sector Challenges12 days ago
CashuIncyte Corporation (INCY): Navigating Mixed Analyst Sentiments in Biopharmaceutical Landscape14 days ago